Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Research Council (Starting grant 716509) to D.A. Pijnappels Background Recently it was demonstrated how the heart itself could be enabled to quickly restore its rhythm by realizing a biologically-integrated cardiac defibrillator (BioICD) through modification and subsequent expression of ion channels in cardiomyocytes [1]. By incorporating these frequency-dependent depolarizing ion channels, abnormal cardiac rhythm could be rapidly detected and terminated to restore sinus rhythm in a fully biological and shock-free manner. However, from a translational point of view, it remains unclear how such rhythm restoration can be realized via ion channel gene therapy. Purpose To explore and understand the importance of the distribution and number of BioICD-expressing cardiomyocytes in realizing fully biological restoration of cardiac rhythm. Methods To this purpose, two different realistic gene therapy configurations, i.e. those corresponding to systemic and local transgene delivery, were tested in a digital twin of human ventricular cardiac monolayers. In the systemic delivery group, BioICD-expressing cells were uniformly distributed over the tissue at different total expression percentages. In the local delivery group, circular areas were populated with BioICD-expressing cells, randomly arranged in a Gaussian distribution. Spiral waves were initiated in both groups and studied for 10 seconds. An additional set of simulations for the systemic delivery group involved an adapted BioICD ion channel with a slower opening and faster closing rate. Results Upon comparing both gene therapy methods, the systemic approach showed a gradually increasing arrhythmia termination chance with increasing BioICD-expression percentage, while local delivery did not result in termination. Instead, local delivery resulted in islands of ionic heterogeneity, causing attraction and anchoring of the spiral waves in a size and distance-dependent manner. Building on the results of the systemic approach, different ion channel parameters were tried, which resulted in normal rhythm being restored in all cases for >50% BioICD expressing cells. Time till termination was inversely related to the percentage, resulting in only 4.3s and 2.5s for 50% and 100%, respectively. Regarding termination, it was observed that conduction blocks appeared throughout the tissue and subsequently connected to force arrhythmic waves to terminate, while this process remained incomplete in the <50% groups. Conclusion This study reveals that wide-spread distribution of BioICD-expressing cardiomyocytes is required for the realization of fully biological self-restoration of cardiac rhythm, of which the efficiency is ion-channel-dynamics- and dosage-dependent. Local expression, however, results in stabilization of spiral wave activity. Further exploration of this emerging concept of biological cardioversion may not only expand our understanding of cardiac arrhythmias, but also pave the way to breakthrough advances in arrhythmia management.

Biological Approaches to Generating Cardiac Biopacemaker for Bradycardia.

Toward Biological Pacing by Cellular Delivery of Hcn2/SkM1

Engineering Human Ventricular Heart Muscles Based on a Highly Efficient System for Purification of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes

Direct Powering a Real Cardiac Pacemaker by Natural Energy of a Heartbeat.

Effect of rectified gap junctional electrical coupling and spatial distribution of biologically engineered pacemaking cells on ventricular excitation

Biomaterial-induced conversion of quiescent cardiomyocytes into pacemaker cells in rats

Effect of Cell Coupling Between Pacemaker Cells on the Biological Pacemaker in Cardiac Tissue Model.

Genetically engineered cardiac pacemaker: stem cells transfected with HCN2 gene and myocytes - a model

HCN2-based biological pacing in a modified rat AV-block model

A new paradigm for generating high-quality cardiac pacemaker cells from mouse pluripotent stem cells

Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model

Thermogenetics for cardiac pacing

State-of-the-Art Differentiation Protocols for Patient-Derived Cardiac Pacemaker Cells

Electrophysiological characterization of hiPSC-derived cardiac pacemaker cells from CPVT bradycardia-associated patients

Symbiotic cardiac pacemaker

Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy

[Transfecting Rat Heart with Human Pacemaker Gene in Vivo to Create a Biological Pacemaker].

Exploring translational approaches for fully biological cardiac rhythm restoration through ion channel gene therapy

Pacemaker Channels and the Chronotropic Response in Health and Disease

A self-powered intracardiac pacemaker in swine model

Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias